FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220700422> ?p ?o ?g. }

• W4220700422 abstract "Background Improved survival rates for children and adolescents diagnosed with cancer call for novel strategies for reducing short- and long-term treatment-related side effects. These include the physical and metabolic sequelae that are exacerbated by sedentary behavior and treatment-induced toxicities. We aim to investigate the effect of an integrative neuromuscular training intervention during the first 6 months of anti-cancer treatment primarily on muscle strength, and secondarily on exercise capacity, physical function, markers of metabolic syndrome, dysmetabolism, and health-related quality of life during and after ended treatment. Methods One hundred and twenty-seven children and adolescents, newly diagnosed with malignant and benign neoplasia, aged 6–17 years, and treated with chemotherapy or radiation will be randomized to either the intervention or the control arm of the study. The intervention group will, in addition to usual care, be offered a combination of 6 months of supervised physical exercise (integrative neuromuscular training) and home-based exercise. The active control group will, in addition to usual care, receive information along an unsupervised written home-based training program. All participants, including parents, will receive information about the importance of physical exercise during the course of cancer treatment, at the start of treatment, and in 5 monthly sessions. The primary outcome is measured in terms of isometric quadriceps muscle strength. Secondary outcomes include muscle strength and endurance, markers of metabolic syndrome and dysmetabolism, exercise capacity, physical function and activity, days of hospitalization, and health-related quality of life. Assessment will be conducted at treatment initiation (baseline), at 3 and 6 months after inclusion, and 1 month and 1 year after ended treatment. The primary endpoint for lower-body muscle strength is at 6 months after treatment initiation. The effects of the intervention will be evaluated through a constrained linear mixed model. Discussion This national randomized controlled study has the potential to provide new knowledge concerning the short- and long-term effects of a novel, inclusive approach for youth exercise programming (integrative neuromuscular exercise) in children and adolescents during anti-cancer treatment. Using a pragmatic, low-cost, and time-efficient training design, this intervention can be easily adapted to both hospital and home settings. Clinical Trial Registration ClinicalTrials.gov (NCT04706676), first released January 5, 2021." @default.
• W4220700422 created "2022-04-03" @default.
• W4220700422 creator A5002112947 @default.
• W4220700422 creator A5015175945 @default.
• W4220700422 creator A5042899853 @default.
• W4220700422 creator A5044945443 @default.
• W4220700422 creator A5048131742 @default.
• W4220700422 creator A5056270039 @default.
• W4220700422 creator A5057818328 @default.
• W4220700422 creator A5064323494 @default.
• W4220700422 creator A5074845542 @default.
• W4220700422 creator A5077277546 @default.
• W4220700422 creator A5084317093 @default.
• W4220700422 creator A5086774156 @default.
• W4220700422 date "2022-03-14" @default.
• W4220700422 modified "2023-09-25" @default.
• W4220700422 title "Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (INTERACT): Study Protocol for a Multicenter, Two-Arm Parallel-Group Randomized Controlled Superiority Trial" @default.
• W4220700422 cites W1486102782 @default.
• W4220700422 cites W1541460789 @default.
• W4220700422 cites W1964576199 @default.
• W4220700422 cites W1967913270 @default.
• W4220700422 cites W1971507298 @default.
• W4220700422 cites W1974704788 @default.
• W4220700422 cites W1974730601 @default.
• W4220700422 cites W1976506183 @default.
• W4220700422 cites W1976626681 @default.
• W4220700422 cites W1978502681 @default.
• W4220700422 cites W1992673855 @default.
• W4220700422 cites W1995629150 @default.
• W4220700422 cites W1996806064 @default.
• W4220700422 cites W1998320290 @default.
• W4220700422 cites W2006015237 @default.
• W4220700422 cites W2006574333 @default.
• W4220700422 cites W2008236720 @default.
• W4220700422 cites W2008283534 @default.
• W4220700422 cites W2015758016 @default.
• W4220700422 cites W2016786264 @default.
• W4220700422 cites W2035947437 @default.
• W4220700422 cites W2037998617 @default.
• W4220700422 cites W2052783921 @default.
• W4220700422 cites W2053241845 @default.
• W4220700422 cites W2054409952 @default.
• W4220700422 cites W2061641643 @default.
• W4220700422 cites W2070093498 @default.
• W4220700422 cites W2071620144 @default.
• W4220700422 cites W2075779916 @default.
• W4220700422 cites W2088831671 @default.
• W4220700422 cites W2094677890 @default.
• W4220700422 cites W2097763212 @default.
• W4220700422 cites W2099065102 @default.
• W4220700422 cites W2099648955 @default.
• W4220700422 cites W2106137934 @default.
• W4220700422 cites W2135344355 @default.
• W4220700422 cites W2139423871 @default.
• W4220700422 cites W2141846678 @default.
• W4220700422 cites W2146054188 @default.
• W4220700422 cites W2153392704 @default.
• W4220700422 cites W2154042628 @default.
• W4220700422 cites W2155443748 @default.
• W4220700422 cites W2161700402 @default.
• W4220700422 cites W2166023752 @default.
• W4220700422 cites W2171546887 @default.
• W4220700422 cites W2174994900 @default.
• W4220700422 cites W2239486811 @default.
• W4220700422 cites W2272724224 @default.
• W4220700422 cites W2315272211 @default.
• W4220700422 cites W2315943804 @default.
• W4220700422 cites W2331615422 @default.
• W4220700422 cites W2333940970 @default.
• W4220700422 cites W2396427850 @default.
• W4220700422 cites W2518957261 @default.
• W4220700422 cites W2542452849 @default.
• W4220700422 cites W2570618306 @default.
• W4220700422 cites W2591485079 @default.
• W4220700422 cites W2599099107 @default.
• W4220700422 cites W2613558324 @default.
• W4220700422 cites W2781692105 @default.
• W4220700422 cites W2782477974 @default.
• W4220700422 cites W2782905460 @default.
• W4220700422 cites W2793792028 @default.
• W4220700422 cites W2801502529 @default.
• W4220700422 cites W2801815388 @default.
• W4220700422 cites W2901069547 @default.
• W4220700422 cites W2910275729 @default.
• W4220700422 cites W2952709937 @default.
• W4220700422 cites W2971845054 @default.
• W4220700422 cites W3039462984 @default.
• W4220700422 cites W3049726169 @default.
• W4220700422 cites W3082785842 @default.
• W4220700422 cites W3174273467 @default.
• W4220700422 cites W36584949 @default.
• W4220700422 cites W4242883546 @default.
• W4220700422 cites W4313209862 @default.
• W4220700422 cites W4375943175 @default.
• W4220700422 doi "https://doi.org/10.3389/fped.2022.833850" @default.
• W4220700422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35359909" @default.
• W4220700422 hasPublicationYear "2022" @default.
• W4220700422 type Work @default.
• W4220700422 citedByCount "1" @default.
• W4220700422 countsByYear W42207004222022 @default.

• next